Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$534M |
| 2 |
Amazon
AMZN
|
+$399M |
| 3 |
Abbott
ABT
|
+$381M |
| 4 |
Adobe
ADBE
|
+$353M |
| 5 |
Oracle
ORCL
|
+$261M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sherwin-Williams
SHW
|
+$407M |
| 2 |
Bank of America
BAC
|
+$368M |
| 3 |
TE Connectivity
TEL
|
+$366M |
| 4 |
Goldman Sachs
GS
|
+$302M |
| 5 |
Atlassian
TEAM
|
+$301M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.57% |
| 2 | Healthcare | 19.51% |
| 3 | Consumer Discretionary | 9.79% |
| 4 | Industrials | 9.79% |
| 5 | Financials | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
IBM
IBM
$213B
| $100M | 0.06% |
612,431
+478,361
| +357% | +$72.3M |
|
|
ETNB
252
DELISTED
89bio
ETNB
| $99.6M | 0.06% |
8,915,141
+4,885,938
| +121% | +$44.9M |
|
253
Regeneron Pharmaceuticals
REGN
$73.2B
| $99.1M | 0.06% |
112,829
-9,584
| -8% | -$7.89M |
|
254
Arthur J. Gallagher & Co
AJG
$69.1B
| $98.5M | 0.06% |
437,799
+408,809
| +1,410% | +$96.8M |
|
255
AXIS Capital
AXS
$7.85B
| $98.3M | 0.06% |
1,775,725
+131,312
| +8% | +$7.3M |
|
256
Mirion Technologies
MIR
$3.72B
| $96.3M | 0.06% |
9,399,185
+671,309
| +8% | +$5.67M |
|
|
CHX
257
DELISTED
ChampionX
CHX
| $96M | 0.06% |
3,287,423
-414,332
| -11% | -$12.8M |
|
258
Ligand Pharmaceuticals
LGND
$5.88B
| $95.9M | 0.06% |
1,343,154
+1,281
| +0.1% | +$75.6K |
|
259
TriNet
TNET
$3.28B
| $95.8M | 0.06% |
805,391
-182,995
| -19% | -$20.9M |
|
|
SWAV
260
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
| $95.6M | 0.06% |
501,733
+182,651
| +57% | +$34.5M |
|
|
ALTR
261
DELISTED
Altair Engineering Inc
ALTR
| $95.3M | 0.06% |
1,131,905
-131,565
| -10% | -$9.15M |
|
262
MACOM Technology Solutions
MTSI
$18B
| $95.1M | 0.06% |
1,022,689
-157,801
| -13% | -$13M |
|
263
Cullen/Frost Bankers
CFR
$10.5B
| $93.3M | 0.06% |
859,979
+17,460
| +2% | +$1.7M |
|
264
Gates Industrial Corporation Ltd.
GTES
$6.37B
| $93.2M | 0.06% |
6,944,386
-561,327
| -7% | -$6.64M |
|
265
Donaldson
DCI
$10.8B
| $92.2M | 0.06% |
1,410,259
-299
| -0% | -$18.2K |
|
266
AvalonBay Communities
AVB
$27.3B
| $92.1M | 0.05% |
491,862
+445,450
| +960% | +$77.7M |
|
267
Arista Networks
ANET
$205B
| $90.5M | 0.05% |
1,537,588
-11,156
| -0.7% | -$586K |
|
268
Verizon
VZ
$201B
| $89.4M | 0.05% |
2,372,831
+1,516,996
| +177% | +$53.7M |
|
269
Shift4
FOUR
$4.38B
| $87.7M | 0.05% |
1,179,149
+597,155
| +103% | +$35.6M |
|
270
VICI Properties
VICI
$29.8B
| $87.3M | 0.05% |
2,738,256
-4,763,190
| -63% | -$140M |
|
|
HI
271
DELISTED
Hillenbrand
HI
| $87.2M | 0.05% |
1,822,186
-210,711
| -10% | -$8.63M |
|
272
Americold
COLD
$4.19B
| $87.1M | 0.05% |
2,874,885
+657,197
| +30% | +$18.4M |
|
|
ACLX
273
DELISTED
Arcellx
ACLX
| $85.4M | 0.05% |
1,538,210
-237,228
| -13% | -$10.7M |
|
274
Williams-Sonoma
WSM
$27.4B
| $85M | 0.05% |
842,084
-187,264
| -18% | -$16.2M |
|
275
Lincoln Electric
LECO
$14.2B
| $84.6M | 0.05% |
389,245
-62,302
| -14% | -$12M |
|
Similar funds
Janus Henderson Group's Q4 2023 Portfolio in Review
As of Q4 2023, Janus Henderson Group held 2,657 positions worth $168B, up 9.8% from $153B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Janus Henderson Group's Q4 2023 filing shows 98 new, 642 increased, 1,760 reduced and 111 closed positions. Its largest new stake was Veralto: 2,881,576 shares worth $237M. The largest sale was Sherwin-Williams, an estimated $407M.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q4 2023 buy was Veralto: 2,881,576 shares worth $237M.
- Janus Henderson Group added most to Eli Lilly in Q4 2023, an estimated $534M increase.
- Janus Henderson Group's biggest Q4 2023 reduction was Sherwin-Williams, cutting an estimated $407M.
- Janus Henderson Group fully exited National Instruments Corp in Q4 2023, selling an estimated $243M.
- Janus Henderson Group's ten largest holdings make up 27% of its $168B portfolio in Q4 2023.
- Janus Henderson Group opened 98 new positions and closed 111 in Q4 2023.
- Janus Henderson Group's portfolio value rose 9.8% quarter-over-quarter to $168B.
Based on Janus Henderson Group's 13F filing for Q4 2023, filed 14 Feb 2024.